Northwell, Indivumed Attain Cancer Research Biobanking Milestone and Extend Joint Partnership

Individualized cancer diagnosis and treatment regimens are the future of oncology care and require harnessing the advances of scientific research. In a milestone moment, Northwell Health and its partner Indivumed GmbH, a Hamburg, Germany-based oncology research company, have successfully consented 1,000 patients,...

Biodesix to Collaborate with Datavant to Boost Value of Lung Cancer Databank

Biodesix, Inc. (Nasdaq: BDSX), a leading lung cancer diagnostic solutions company, announced a strategic partnership with Datavant, a leader in helping healthcare organizations safely connect their data. Datavant provides solutions to help protect, match, and share health data. Through this partnership, Biodesix...

A Population-Based Prospective Study to Establish an Link Between Body Composition and Gastric Cancer

Gastric cancer is one of the most common and deadly cancers worldwide. Data from the GLOBOCAN database showed that gastric cancer was responsible for over 1,033,000 new cases and 78,200 deaths in 2018, ranking fifth for cancer incidence and...

Utilizing Biobank Data to Correlate Adiposity with Cancer Incidence and Mortality

Obesity has strong association with increased incidence of, and premature mortality from, some types of cancer1. However, a study by the World Cancer Research Fund (WCRF) report also highlighted the lack of evidence regarding the association of cancer with...

Colorectal Cancer: A Biobank of Patient-derived Xenografts

According to GLOBOCAN 2018 data, colorectal cancer (CRC) is the third most deadly and fourth most commonly diagnosed cancer in the world. There were nearly 2 million new cases and about 1 million deaths in 2018. The incidence of...

A Living Biobank Of Ovarian Cancer – A Model For Drug Discovery

Synthetic lethality is a circumstance in which a drug is selectively deadly to cancer cells due to the mutations and genetic changes that have occurred during oncogenesis and progression. Oftentimes a cancer will lose redundancy, that is it will jettison certain survival/...
Biobanking and colorectal cancer tissues

Biobanking Science: Biobanking Samples for Colorectal Cancer

Colorectal cancer is the third most common cancer, affecting 1.8 million new patients and causing 862,000 deaths every year (1). Studies show that eating processed or red meat and drinking alcohol may increase the risk for colorectal cancer (2)....

⭐ Recently Featured

🔥 Popular Posts

X